Journal of Genetic Counseling

, Volume 16, Issue 4, pp 469–479 | Cite as

Psychological Follow-up of Presymptomatic Genetic Testing for Spinocerebellar Ataxia Type 2 (SCA2) in Cuba

  • Milena Paneque
  • Carolina Lemos
  • Karell Escalona
  • Lizandra Prieto
  • Rubén Reynaldo
  • Mercedes Velázquez
  • Judith Quevedo
  • Nieves Santos
  • Luis Enrique Almaguer
  • Luis Velázquez
  • Alda Sousa
  • Manuela Fleming
  • Jorge Sequeiros
Original Research

Presymptomatic testing for spinocerebellar ataxia type 2 (SCA2) in Cuba started five years ago. We have now investigated the psychological impact of test results on 150 individuals at 50% risk for SCA2. In a prospective study, psychological instruments were used to evaluate depression, anxiety and family functioning (1) before testing and (2) one year after disclosure of the test result. One year after, anxiety and depression levels decreased both in carriers and non-carriers, but anxiety decreased significantly more in carriers. Pathological levels of anxiety were seen mostly in members of dysfunctional families, but decreased more in them than in other consultands. Presymptomatic testing thus seems to have been especially beneficial for these testees, possibly due to a greater gain from the psychosocial support received. It would be pertinent to evaluate now the impact of other psychosocial variables and perform longer-term longitudinal studies.

KEY WORDS

predictive testing psychosocial genetics late-onset neurological disorders hereditary ataxia anxiety depression family functioning 

REFERENCES

  1. Almqvist, E., Bloch, M., Brinkman, R., Craufurd, D., & Hayden, M., on behalf of an international HD collaborative group (1999). A worldwide assessment of the frequency of suicide attempts, or psychiatric hospitalization after predictive testing for HD. Am J Hum Genet, 64, 1293–1304.PubMedCrossRefGoogle Scholar
  2. Almqvist, E. W., Brinkman, R. R., Wiggins, S., & Hayden, M. R., The Canadian Collaborative Study of Predictive Testing (2003). Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington’s disease. Clin Genet, 64, 300–309.PubMedCrossRefGoogle Scholar
  3. Babul, R., Adam, S., Kremer, B., Dufrasne, S., Wiggins, S., & Huggins, M. (1993). Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease. JAMA, 19, 2321–2325.CrossRefGoogle Scholar
  4. Beck, T., Ward, C., & Mendelson, M. (1961). An inventory for measuring depression. Arch Gen Psychiatry, 4, 561–571.PubMedGoogle Scholar
  5. Bloch, M., Adam, S., Wiggins, S., Huggins, M., & Hayden, M. (1992). Predictive testing for Huntington’s disease in Canada: The experience of those receiving an increased risk. Am J Med Genet, 42, 499–507.PubMedCrossRefGoogle Scholar
  6. Bloch, M., Fahy, M., Fox, S., & Hayden M. (1989). Predictive testing for Huntington’s disease: Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one tests candidates. Am J Med Genet, 32, 217–224.PubMedCrossRefGoogle Scholar
  7. Brandt, J., Quaid, K., Folstein S., Garber, P., Maestri, N., Abbott, M., et al. (1989). Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington’s disease. JAMA, 261, 3108–3114.PubMedCrossRefGoogle Scholar
  8. Broadstock, M., Michie, S., & Marteau, T. (2000). Psychological consequences of predictive genetic testing: A systematic review. Eur J Hum Gen, 8, 731–738.CrossRefGoogle Scholar
  9. Brower-DudokdeWit, A., Savenije, A., Zoeteweij, M., Maat Kievit, A., & Tibben, A. (2000). A hereditary disorder in the family and the family life cycle: Huntington Disease as a paradigm. Fam Process, Winter.Google Scholar
  10. Bonke, B., Smorenburg, J., & Kors Van Der Ent, C. (1987) Evidence of denial and item-intensity specificity in the State-Trait Anxiety Inventory. Person Individ Diff, 8, 185–191.CrossRefGoogle Scholar
  11. Codori, A., Hanson, R., & Brandt, J. (1994). Self-selection in predictive testing for Huntington’s disease. Am J Med Genet, 54, 167–173.PubMedCrossRefGoogle Scholar
  12. Codori, A. M., Slavney, P. R., Young, C., Miglioretti, D. L., & Brandt, J. (1997). Predictors of psychological adjustment to genetic testing for Huntington’s disease. Health Psychol, 16, 36–50.PubMedCrossRefGoogle Scholar
  13. Codori, A. M., Slavney, P. R., Rossenblatt, A., & Brandt, J. (2004). Prevalence of major depression one year after predictive testing for Huntington’s disease. Genet Test, 8, 114–119.PubMedCrossRefGoogle Scholar
  14. Craufurd, D., Kerzin-Storrar, L., & Harris, R. (1989). Uptake of presymptomatic predictive testing for Huntington’s disease. Lancet, 2, 603–605.PubMedCrossRefGoogle Scholar
  15. De la Cuesta, F., Ortega, T., & Días, C. (1999). Propuesta de un instrumento para la aplicación del proceso de atención de enfermería en familias disfuncionales. Rev Cub Enfer, 15, 164–168.Google Scholar
  16. Decruyenaere, M., Evers-Kiebooms, G., & Boogaerts, A. (1996). Prediction of psychological functioning one year after the predictive test for Huntington’s disease and impact of the result on reproductive decision making. J Med Gen, 33, 737–743.Google Scholar
  17. Decruyenaere, M., Evers-Kiebooms, G., Boogaerts, A., Cassiman, J., Cloostermans, T., Demyttenaere, K., et al. (1995). Predictive testing for Huntington's disease: Risk perception, reasons for testing and psychological profile of test applicants. Genet Counsel, 6, 1–13.Google Scholar
  18. Decruyenaere, M., Evers-Kiebooms, G., Boogaerts, A., Cassiman, J., Cloostermans, T., Demyttenaere, K., et al. (1999). Psychological functioning before predictive testing for Huntington’s disease: The role of the parental disease, risk perception, and subjective proximity of the disease. J Med Gen, 36, 897–905.Google Scholar
  19. Duisterhof, M., Trijsburg, R., Niermeijer, M., Roos, R., & Tibben, A. (2001). Psychological studies in Huntington’s disease: Making up the balance. J Med Gent, 38, 852–861.CrossRefGoogle Scholar
  20. European Community Huntington Disease Collaborative Study Group. (1993). Ethical and social issues in presymptomatic testing for Huntington’s disease: A European Community collaborative study. J Med Genet, 30, 1028–1035.CrossRefGoogle Scholar
  21. Evers-Kiebooms, G., & Decruyenaere, M. (1998). Predictive testing for Huntington’s disease: A challenge for persons at risk and for professionals. Patient Educ Counsel, 35, 15–26.CrossRefGoogle Scholar
  22. Fleming, M., Lêdo, S., Rocha, J., & Sequeiros, J. (2004). Impacto psicológico do teste predictivo na doença de Machado Joseph: Resultados preliminares. Arq Medicina, 18, 72–75.Google Scholar
  23. Gispert, S., Twells, R., Orozco, G., Brice, A., Wever, J., & Heredero, L. (1993). Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1. Nat Genet, 4, 29–59.CrossRefGoogle Scholar
  24. Goizet, C., Lesca, G., & Dürr, A., on behalf of the French Group for Presymptomatic Testing in Neurogenetic Disorders. (2002). Presymptomatic testing for Huntington’s disease and autosomal dominant cerebellar ataxias. Neurology, 59, 1330–1336.PubMedGoogle Scholar
  25. Gonzalez, C., Lima, M., Kay, T., Silva, C., Santos, C., & Santos, J. (2004). Short-term psychological impact of predictive testing for Machado-Joseph disease: Depression and anxiety levels in individuals at risk from the Azores (Portugal). Community Genet, 7, 196–201.PubMedCrossRefGoogle Scholar
  26. Huggins, M., Bloch, M., Wiggins, S., Adam, S., Suchowersky, O., Trew, M., et al. (1992). Predictive testing for Huntington disease in Canada: Adverse effects and unexpected results in those receiving a decreased risk. Am J Med Genet, 42, 508–515.PubMedCrossRefGoogle Scholar
  27. Kessler, S. (1994). Predictive testing for Huntington disease: A psychologist’s view [editorial comment]. Am J Med Genet, 54, 161–166.PubMedCrossRefGoogle Scholar
  28. Laccone, F., Engel, U., Holinski-Feder, E., Weigell-Weber, M., Marczinek, K., Nolte, D., et al. (1999). DNA analysis of Huntington disease: Five years of experience in Germany, Austria and Switzerland. Neurology, 53, 801–806.PubMedGoogle Scholar
  29. Marteau, M. T., & Croyle R. T. (1998). The new genetics: Psychological responses to genetic testing. BMJ, 28, 693–696.Google Scholar
  30. Meissen, J., Mastromauro, A., Kiely, K., McNamara, S., & Myers, H. (1991). Understanding the decision to take the predictive test for Huntington’s disease. Am J Med Genet, 39, 404–410.PubMedCrossRefGoogle Scholar
  31. Orozco, G., Nodarse, A., Cordovés, R., & Aurburger, G. (1990). Autosomal dominant cerebellar ataxia: Clinical analysis of 263 patients from a homogeneous population in Holguín, Cuba. Neurology, 40, 1369–1375.Google Scholar
  32. Paneque, M., Prieto, L., Reynaldo, R., Cruz, T., Santos, N., Almaguer, L., et al. (2006). Presymptomatic diagnosis of spinocerebellar ataxia type 2 in Cuba: A preliminary valoration. Community Genet (in press).Google Scholar
  33. Pulst, S. M., Nechiporuk, A., Nechiporuk, T., Gispert, S., Chen, X. N., Lopes-Cendes, I., et al. (1996). Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet, 14, 269–276.PubMedCrossRefGoogle Scholar
  34. Quaid, A., & Wesson, M. (1995). Exploration of the effects of Predictive testing for Huntington disease on intimate relationships. Am J Med Genet, 57, 46–51.PubMedCrossRefGoogle Scholar
  35. Rapaport, D., Schafer, R., & Gill, M. M. (1946). Diagnostic Psychological Testing. Chicago, Ill: Year Book Publishers.Google Scholar
  36. Rolim, L., Leite, A., Ledo, S., Paneque, M., Sequeiros, J., & Fleming, M. (2006). Psychological aspects of pre-symptomatic testing for Machado-Joseph disease and familial amyloid polyneuropathy type I. Clin Genet, 69, 297–305.PubMedCrossRefGoogle Scholar
  37. Rolland, S., & Williams, J. (2005). Toward a biopsychosocial model for 21st century genetics. Fam Process, 44, 3–24.PubMedCrossRefGoogle Scholar
  38. Sequeiros, J. (1996). Protocolo Geral do Programa Nacional de Teste Preditivo e o aconselhamento Genético na Doença de Machado-Joseph. In J. Sequeiros (Ed.), O Teste Preditivo da Doença de Machado-Joseph (pp. 123–149). Porto: UnIGENe, IBMC.Google Scholar
  39. Sobel, S., & Cowan, D. B. (2003). Ambiguous loss and disenfranchised grief: The impact of DNA predictive testing on the family as a system. Fam Process, 42, 47–57.PubMedCrossRefGoogle Scholar
  40. Solís-Pérez, M., Burguesa, J., Palau, F., Livianos, L., Vila, M., & Rojo, L. (2001). Resultados de un programa de diagnóstico presintomático en la enfermedad de Huntington: Evaluación de un período de 6 años. Rev Neurol Esp, 16, 348–352.Google Scholar
  41. Spielberger, D., Gorsuch, L., & Lushene, E. (Eds.). (1970). Manual for the Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychological Press.Google Scholar
  42. Tibben, A., Vegter-vd Vlis, M., Skraastad, I., Frets, G., Kamp, P., Niermeijer, F., et al. (1992). DNA testing for Huntington disease in The Netherlands: A retrospective study on psychosocial effects. Am J Med Genet, 44, 94–99.PubMedCrossRefGoogle Scholar
  43. Tibben, A. (1993). What is knowledge but grieving? On psychological effects of presymptomatic DNA-testing for Huntington’s disease. PhD thesis. Erasmus University of Rotterdam.Google Scholar
  44. Tibben, A., Duivenvoorden, M., Martinus, F., Niermeijer, F., Van Der Vlis, M. V., Roos, R. A., et al. (1994). Psychological effects of presymptomatic DNA Testing for Huntington’s disease in the Dutch program. Psychosomatic Med, 56, 526–532.Google Scholar
  45. Tibben, A., Timman, R., Bannink, C., & Duivenvoorden, J. (1997). Tree year follow-up after presymptomatic testing for HD in tested individuals and partners. Health Psych, 16, 20–35.CrossRefGoogle Scholar
  46. Velázquez, L., Santos, N., García, R., Paneque, M., & Hechavarría, R. (2001). Epidemiología de la ataxia hereditaria cubana. Rev Neurol Esp, 32, 606–611.Google Scholar
  47. Wiggins, S., Whyte, P., Huggins, M., Adam, S., Theilmann, J., Bloch, M., et al. (1992). The psychological consequences of predictive testing for Huntington’s disease. N Engl J Med, 327, 1401–1405.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Milena Paneque
    • 1
    • 2
    • 4
  • Carolina Lemos
    • 3
  • Karell Escalona
    • 1
  • Lizandra Prieto
    • 1
  • Rubén Reynaldo
    • 1
  • Mercedes Velázquez
    • 1
  • Judith Quevedo
    • 1
  • Nieves Santos
    • 1
  • Luis Enrique Almaguer
    • 1
  • Luis Velázquez
    • 1
  • Alda Sousa
    • 3
  • Manuela Fleming
    • 2
    • 3
  • Jorge Sequeiros
    • 2
    • 3
  1. 1.Clínica para Investigación y Rehabilitación de las Ataxias Hereditarias (CIRAH)HolguínCuba
  2. 2.Centro de Genética Preditiva e Preventiva (CGPP) and UnIGENe, IBMCPortoPortugal
  3. 3.ICBASUniversity of PortoPortoPortugal
  4. 4.CGPP, IBMCUniversity of PortoPortoPortugal

Personalised recommendations